3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Unknown
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Breast Neoplasms
1476
Neoplasms
999
Colorectal Neoplasms
830
Carcinoma, Non-Small-Cell Lung
724
Carcinoma, Hepatocellular
683
Stomach Neoplasms
647
Lung Neoplasms
584
Prostatic Neoplasms
543
Pancreatic Neoplasms
456
Rectal Neoplasms
338
Uterine Cervical Neoplasms
303
Colonic Neoplasms
295
Neoplasm Metastasis
292
Ovarian Neoplasms
285
Esophageal Neoplasms
279
Recurrence
278
Leukemia, Myeloid, Acute
253
Head and Neck Neoplasms
241
Multiple Myeloma
232
Brain Neoplasms
204
Polycystic Ovary Syndrome
200
Nasopharyngeal Carcinoma
198
Melanoma
198
Precursor Cell Lymphoblastic Leukemia-Lymphoma
195
Urinary Bladder Neoplasms
193
Lymphoma
178
Liver Neoplasms
178
Endometrial Neoplasms
159
Motor Activity
147
Lymphoma, Large B-Cell, Diffuse
141
Interventions
niraparib
1
anlotinib
1
PHI-101
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
OTHER
×
Platinum-resistant Ovarian Cancer
×
Clear all
NCT04678102
2023-06-26
CREATIVE
Seoul National University Hospital
Phase 1
Unknown
36 enrolled
NCT04376073
2020-11-25
ANNIE
Sun Yat-sen University
Phase 2
Unknown
40 enrolled